Acadian Asset Management Has Raised Genomic Health (GHDX) Stake by $934,774; Griffin Asset Management Has Increased Its Stake in Kinder Morgan (KMI) as Market Valuation Declined

June 14, 2018 - By Michael Collier

Genomic Health, Inc. (NASDAQ:GHDX) Logo

Acadian Asset Management Llc increased its stake in Genomic Health Inc (GHDX) by 722.25% based on its latest 2018Q1 regulatory filing with the SEC. Acadian Asset Management Llc bought 30,154 shares as the company’s stock rose 19.89% while stock markets declined. The institutional investor held 34,329 shares of the health care company at the end of 2018Q1, valued at $1.07 million, up from 4,175 at the end of the previous reported quarter. Acadian Asset Management Llc who had been investing in Genomic Health Inc for a number of months, seems to be bullish on the $1.72 billion market cap company. The stock decreased 2.83% or $1.42 during the last trading session, reaching $48.68. About 152,392 shares traded. Genomic Health, Inc. (NASDAQ:GHDX) has risen 30.62% since June 14, 2017 and is uptrending. It has outperformed by 18.05% the S&P500. Some Historical GHDX News: 08/03/2018 – RPT-GENOMIC HEALTH INC – SEES 2018 REVENUE FROM $ 366 MLN TO $382 MLN; 21/05/2018 – Genomic Health: New Data Reinforce Positive Impact of Oncotype DX Genomic Prostate Score Test in Guiding Treatment; 22/04/2018 – DJ Genomic Health Inc, Inst Holders, 1Q 2018 (GHDX); 15/05/2018 – BC Platforms Partners with Google Cloud to Offer Transformational and Scalable Genomic Solutions Worldwide; 26/04/2018 – Large Independent Study Using the Oncotype DX® Test Accepted for Presentation at 2018 American Society of Clinical Oncology (ASCO) Annual Meeting; 21/03/2018 – Genomic Vision: 2017 Annual Results; 19/05/2018 – Veracyte Announces That Data From Multiple Studies Demonstrate “Real-World” Value of Afirma Genomic Sequencing Classifier in Thyroid Cancer Diagnosis; 06/03/2018 – Shivom Partnership With Genetic Technologies Will Enable Better Cancer Prediction and Prevention Through Mass Genomic Data; 08/03/2018 – GENOMIC HEALTH SEES FY EPS 32C TO 50C, EST. 34C; 26/04/2018 – Large Independent Study Using the Oncotype DX® Test Accepted for Presentation at 2018 American Society of Clinical Oncology (A

Griffin Asset Management Inc increased its stake in Kinder Morgan Inc (KMI) by 56.87% based on its latest 2018Q1 regulatory filing with the SEC. Griffin Asset Management Inc bought 21,664 shares as the company’s stock declined 6.09% with the market. The institutional investor held 59,758 shares of the public utilities company at the end of 2018Q1, valued at $900,000, up from 38,094 at the end of the previous reported quarter. Griffin Asset Management Inc who had been investing in Kinder Morgan Inc for a number of months, seems to be bullish on the $37.36B market cap company. The stock increased 1.16% or $0.195 during the last trading session, reaching $16.935. About 6.00 million shares traded. Kinder Morgan, Inc. (NYSE:KMI) has declined 18.18% since June 14, 2017 and is downtrending. It has underperformed by 30.75% the S&P500. Some Historical KMI News: 18/04/2018 – Kinder Morgan says investment in oil pipeline expansion may be untenable; 26/04/2018 – Kinder Morgan Has Threatened to Scrap Trans Mountain Expansion by May 31; 08/04/2018 – KINDER MORGAN CANADA LTD – KML WILL CONSULT WITH VARIOUS STAKEHOLDERS IN AN EFFORT TO REACH AGREEMENTS BY MAY 31ST THAT MAY ALLOW PROJECT TO PROCEED; 30/05/2018 – EL PASO NATURAL GAS COMPANY DECLARES FORCE MAJEURE ON LINE 2000 DUE TO AN ANOMALY ON LINE, DOWNSTREAM OF LORDSBURG COMPRESSOR STATION; 12/04/2018 – Globalnews.ca: #BREAKING: Prime Minister Justin Trudeau will be flying back to Canada from Peru this weekend for a joint; 29/05/2018 – ALBERTA PREMIER SAYS AT THIS POINT DOESN’T THINK ALBERTA BUYING TRANS MOUNTAIN IS NECESSARY; 29/05/2018 – KINDER MORGAN CANADA: GOVT TO FUND RESUMPTION OF TMEP PLANNING; 18/04/2018 – KINDER MORGAN STILL SEES FY DCF/SHARE $2.05; 11/04/2018 – CANADA FINANCE MINISTER SAYS DOESN’T SEE A NEED TO REFER THE MATTER TO THE SUPREME COURT; 26/04/2018 – British Columbia Asks Court to Rule on Authority Over Kinder Morgan Project

Since December 19, 2017, it had 0 insider purchases, and 15 sales for $7.32 million activity. Another trade for 3,374 shares valued at $111,080 was made by Leber Laura on Tuesday, February 20. Febbo Phillip G. had sold 5,334 shares worth $197,298. The insider Popovits Kimberly J sold 10,000 shares worth $380,877. Cole G Bradley had sold 5,000 shares worth $177,566 on Tuesday, January 9. $201,543 worth of Genomic Health, Inc. (NASDAQ:GHDX) was sold by Shak Steven on Wednesday, May 9.

More important recent Genomic Health, Inc. (NASDAQ:GHDX) news were published by: 247Wallst.com which released: “Top Analyst Upgrades and Downgrades: Applied Materials, Comcast, HUYA, Sprint, Time Warner, Yelp and More” on June 13, 2018, also Streetinsider.com published article titled: “Pre-Open Movers 06/04: (VSAR) (VYGR) (GHDX) Higher; (NKTR) (JNCE) (CFX) Lower (more…)”, Fool.com published: “Here’s Why Genomic Health Rocketed Higher Today” on June 04, 2018. More interesting news about Genomic Health, Inc. (NASDAQ:GHDX) was released by: Investorplace.com and their article: “Is This the Latest Booster for Medtronic PLC Stock?” with publication date: June 14, 2018.

Among 12 analysts covering Genomic Health (NASDAQ:GHDX), 2 have Buy rating, 3 Sell and 7 Hold. Therefore 17% are positive. Genomic Health had 36 analyst reports since August 5, 2015 according to SRatingsIntel. William Blair downgraded the shares of GHDX in report on Wednesday, December 20 to “Hold” rating. Canaccord Genuity maintained Genomic Health, Inc. (NASDAQ:GHDX) rating on Monday, September 25. Canaccord Genuity has “Buy” rating and $35.0 target. The stock of Genomic Health, Inc. (NASDAQ:GHDX) has “Neutral” rating given on Monday, January 11 by Piper Jaffray. Canaccord Genuity maintained the shares of GHDX in report on Monday, June 4 with “Buy” rating. The stock of Genomic Health, Inc. (NASDAQ:GHDX) earned “Hold” rating by Jefferies on Friday, October 20. The rating was downgraded by Zacks on Thursday, August 6 to “Hold”. The company was upgraded on Monday, August 24 by Zacks. The stock of Genomic Health, Inc. (NASDAQ:GHDX) earned “Underweight” rating by JP Morgan on Wednesday, December 13. As per Friday, March 9, the company rating was maintained by Canaccord Genuity. J.P. Morgan downgraded Genomic Health, Inc. (NASDAQ:GHDX) rating on Wednesday, December 13. J.P. Morgan has “Sell” rating and $25.0 target.

Investors sentiment increased to 1.42 in Q1 2018. Its up 0.29, from 1.13 in 2017Q4. It is positive, as 16 investors sold GHDX shares while 29 reduced holdings. 24 funds opened positions while 40 raised stakes. 31.06 million shares or 0.50% less from 31.21 million shares in 2017Q4 were reported. Parametric Portfolio Assocs Lc owns 0% invested in Genomic Health, Inc. (NASDAQ:GHDX) for 15,946 shares. The Texas-based Hbk Limited Partnership has invested 0% in Genomic Health, Inc. (NASDAQ:GHDX). Us Financial Bank De invested in 1,611 shares. Macquarie Group holds 38,000 shares. Smithfield Trust Com accumulated 100 shares. Fmr Ltd Liability Co invested in 132,891 shares or 0% of the stock. The Georgia-based Signaturefd Limited Liability Co has invested 0% in Genomic Health, Inc. (NASDAQ:GHDX). Legal And General Grp Public Limited stated it has 0% of its portfolio in Genomic Health, Inc. (NASDAQ:GHDX). Aqr Cap Management Ltd Liability Com accumulated 148,223 shares. Royal Retail Bank Of Canada, a Ontario – Canada-based fund reported 161 shares. Strs Ohio accumulated 24,800 shares. Dekabank Deutsche Girozentrale reported 17,000 shares. California Employees Retirement holds 61,500 shares. Trexquant Inv Limited Partnership holds 17,610 shares or 0.04% of its portfolio. State Common Retirement Fund accumulated 22,900 shares or 0% of the stock.

Acadian Asset Management Llc, which manages about $65.15B and $23.12 billion US Long portfolio, decreased its stake in Stars Group Inc by 225,317 shares to 313,783 shares, valued at $8.66M in 2018Q1, according to the filing. It also reduced its holding in Petmed Express Inc (NASDAQ:PETS) by 169,304 shares in the quarter, leaving it with 303,952 shares, and cut its stake in Boingo Wireless Inc (NASDAQ:WIFI).

Among 25 analysts covering Kinder Morgan (NYSE:KMI), 17 have Buy rating, 0 Sell and 8 Hold. Therefore 68% are positive. Kinder Morgan had 86 analyst reports since July 30, 2015 according to SRatingsIntel. The stock of Kinder Morgan, Inc. (NYSE:KMI) earned “Outperform” rating by Wolfe Research on Thursday, October 20. The stock has “Overweight” rating by JP Morgan on Monday, February 12. The rating was upgraded by Morgan Stanley on Thursday, August 18 to “Overweight”. The rating was maintained by Stifel Nicolaus with “Buy” on Monday, April 30. The firm earned “Overweight” rating on Thursday, October 22 by Barclays Capital. As per Wednesday, May 30, the company rating was maintained by Morgan Stanley. On Thursday, October 20 the stock rating was upgraded by Stifel Nicolaus to “Buy”. The company was downgraded on Thursday, March 17 by Credit Suisse. The stock has “Hold” rating by RBC Capital Markets on Sunday, October 1. As per Thursday, October 20, the company rating was upgraded by Credit Suisse.

Griffin Asset Management Inc, which manages about $394.93 million and $549.46M US Long portfolio, decreased its stake in General Electric (NYSE:GE) by 44,557 shares to 232,418 shares, valued at $3.13M in 2018Q1, according to the filing. It also reduced its holding in Union Pac Corp. (NYSE:UNP) by 10,050 shares in the quarter, leaving it with 8,850 shares, and cut its stake in Dover Corp (NYSE:DOV).

More notable recent Kinder Morgan, Inc. (NYSE:KMI) news were published by: Nasdaq.com which released: “2 Top Dividend Stocks to Buy Now” on June 13, 2018, also Seekingalpha.com with their article: “Canada to buy Trans Mountain pipeline” published on May 29, 2018, Fool.com published: “Energy Investors Are Overlooking Kinder Morgan’s Huge Growth Opportunity” on June 11, 2018. More interesting news about Kinder Morgan, Inc. (NYSE:KMI) were released by: Seekingalpha.com and their article: “Kinder Morgan Starts Over” published on May 30, 2018 as well as Seekingalpha.com‘s news article titled: “Kinder Morgan Drops A Shocking Bombshell: 5 Things Investors Need To Know” with publication date: June 13, 2018.

Kinder Morgan, Inc. (NYSE:KMI) Institutional Positions Chart

Echostar Corporation-Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


>